(Q41930806)

14 October 2017

title

Fetal growth restriction and birth defects with newer and older antiepileptic drugs during pregnancy (English)

1 reference

intrauterine growth restriction

14 October 2017

main subject

1 reference

4

Nils Erik Gilhus

1 reference

14 October 2017

Gyri Veiby

1

1 reference

14 October 2017

Anne Kjersti Daltveit

series ordinal

2

1 reference

14 October 2017

Bernt A Engelsen

series ordinal

3

1 reference

14 October 2017

language of work or name

1 reference

22 January 2014

1 reference

14 October 2017

1 reference

14 October 2017

volume

261

1 reference

14 October 2017

issue

3

1 reference

14 October 2017

page(s)

579-588

1 reference

Pregnancy, delivery, and outcome for the child in maternal epilepsy.

14 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7239-X

Practice parameter update: management issues for women with epilepsy--focus on pregnancy (an evidence-based review): teratogenesis and perinatal outcomes: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcom

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7239-X

Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7239-X

Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7239-X

Foetal antiepileptic drug exposure and verbal versus non-verbal abilities at three years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7239-X

Effects of fetal antiepileptic drug exposure: outcomes at age 4.5 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7239-X

Language skills of school-aged children prenatally exposed to antiepileptic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7239-X

The behavioral consequences of exposure to antiepileptic drugs in utero

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7239-X

Exposure to antiepileptic drugs in utero and child development: a prospective population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7239-X

Early child development and exposure to antiepileptic drugs prenatally and through breastfeeding: a prospective cohort study on children of women with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7239-X

Generalized tonic-clonic seizures and antiepileptic drugs during pregnancy--a matter of importance for the baby?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7239-X

Fetal heart rate during a maternal grand mal epileptic seizure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7239-X

Seizure control and treatment in pregnancy: observations from the EURAP epilepsy pregnancy registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7239-X

21 January 2018

Microcephaly syndromes

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7239-X

Population-based study of antiepileptic drug exposure in utero--influence on head circumference in newborns

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7239-X

Adult consequences of fetal growth restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7239-X

Head growth in preterm infants: correlation with magnetic resonance imaging and neurodevelopmental outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7239-X

Small for gestational age: short stature and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7239-X

The FDA's assessment of two drugs for chronic weight management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7239-X

The outcome of pregnancy following topiramate treatment: a study on 52 pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7239-X

Weight change associated with antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7239-X

Newer-Generation Antiepileptic Drugs and the Risk of Major Birth Defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7239-X

Newer anticonvulsants: lamotrigine, topiramate and gabapentin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7239-X

Valproic acid monotherapy in pregnancy and major congenital malformations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7239-X

Teratogenesis in repeated pregnancies in antiepileptic drug-treated women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7239-X

Influence of the MTHFR genotype on the rate of malformations following exposure to antiepileptic drugs in utero

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7239-X

Genetic basis of susceptibility to teratogen induced birth defects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7239-X

Genetic susceptibility to teratogens: state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7239-X

Prescription drug use among fathers and mothers before and during pregnancy. A population-based cohort study of 106,000 pregnancies in Norway 2004-2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7239-X

Birthweight by gestational age in Norway

21 January 2018

1 reference

12 December 2020

Saving Mothers' Lives: Reviewing maternal deaths to make motherhood safer: 2006-2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom

1 reference

12 December 2020

Intellectual and language functions in children of mothers with epilepsy.

1 reference

12 December 2020

Psychomotor development in preschool children exposed to antiepileptic drugs in utero.

1 reference

12 December 2020

Obstetric outcome in women with epilepsy: a hospital-based, retrospective study

1 reference

12 December 2020

Fetal effects of anticonvulsant polytherapies: different risks from different drug combinations

1 reference

12 December 2020

Myasthenia gravis in pregnancy and birth: identifying risk factors, optimising care

1 reference

12 December 2020

Teratogenic effects of antiepileptic drugs

1 reference

12 December 2020

Validity of a rheumatic disease diagnosis in the Medical Birth Registry of Norway

1 reference

12 December 2020

Complications during pregnancy in women with epilepsy: population-based cohort study

1 reference

12 December 2020

Affect of Seizures During Gestation on Pregnancy Outcomes in Women With Epilepsy

1 reference

12 December 2020

10.1007/S00415-013-7239-X

Identifiers

DOI

1 reference

14 October 2017

1 reference